跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Avaprel - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Avaprel
Approved
STANDARD
Avaprel
Interphil Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
931d91915beb1022
Company
Interphil Laboratories Inc.
Type
Standard
Approval Details
Approval Id
931d91915beb1022
Drug Approval Philippines Name
Avaprel
Product Name
Avaprel
Registration Number
DRP-3839-04
Brand Name
Avaprel
Generic Name
Irbesartan
Dosage Form
Tablet
Dosage Strength
150mg
Manufacturer
Interphil Laboratories Inc.
Distributor
Pharma Hub Corporation
Issuance Date
26 October 2021
Expiry Date
16 May 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
931d91915beb1022
Type
Standard
Back to Philippines FDA Approvals